Ada Wiśniewska

Kamal Adawi is an experienced finance professional currently serving as the Chief Financial Officer at Mindera Health since August 2024. Prior to this role, Kamal held the position of Chief Financial Officer at Exagen Inc. from 2017 to August 2024, where an initial public offering was successfully completed on September 19, 2019. Additional experience includes serving as Chief Financial Officer at Pathway Genomics Corporation from 2014 to 2017, Director of Financial Planning & Analysis at Exagen Inc. in 2013-2014, and Manager of Financial Planning & Analysis at GenMark Diagnostics from 2011 to 2013. Kamal began a career in finance as a Senior Financial Analyst at BD from 2003 to 2008. Academic credentials include a Bachelor of Arts in Finance from Michigan State University - Eli Broad College of Business, a Master of Science in Finance from San Diego State University, and an MBA from Oakland University.